Evercore ISI started coverage on shares of Health Catalyst (NASDAQ:HCAT) in a research report released on Monday, BenzingaRatingsTable reports. The firm issued an outperform rating and a $50.00 target price on the stock.
NASDAQ HCAT opened at $43.66 on Monday. Health Catalyst has a 12 month low of $36.29 and a 12 month high of $49.85.
About Health Catalyst
Further Reading: Green Investing
Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.